Will Rigel Pharmaceuticals, Inc. (RIGL) Underperform the Rest of the Stocks in the Healthcare Sector?

The 5 rating InvestorsObserver gives to Rigel Pharmaceuticals, Inc. (RIGL) stock puts it near the bottom of the Healthcare sector. In addition to scoring higher than 29 percent of stocks in the Healthcare sector, RIGL’s 5 overall rating means the stock scores better than 5 of all stocks.

RIGL has an Overall Score of 5. Find out what this means to you and get the rest of the rankings on RIGL!

See Full RIGL Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Rigel Pharmaceuticals, Inc. Stock Today?

Rigel Pharmaceuticals, Inc. (RIGL) stock is higher by 21.25% while the S&P 500 is down -3.57% as of 2:22 PM on Thursday, Jun 16. RIGL has gained $0.17 from the previous closing price of $0.81 on volume of 14,952,993 shares. Over the past year the S&P 500 is down -13.47% while RIGL is down -76.43%. RIGL lost -$0.50 per share the over the last 12 months. Click Here to get the full Stock Report for Rigel Pharmaceuticals, Inc. stock.